AXON insider sale: Chief Accounting Officer disposed of 77 shares under 10b5-1 plan

Rhea-AI Filing Summary

Jennifer H. Mak, Chief Accounting Officer of Axon Enterprise, Inc. (AXON), reported a sale of 77 shares of common stock on 09/15/2025. The sale was effected under a Rule 10b5-1 trading plan adopted March 14, 2025, and related to shares issued upon settlement of vested restricted stock units. The reported sale price was $760 per share. After the transaction, Ms. Mak beneficially owned 15,003 shares directly. The Form 4 was signed by an attorney-in-fact on her behalf.

Insights

Financial Analyst

TL;DR: Insider sale of 77 shares under a 10b5-1 plan; small position reduction relative to reported direct holdings.

The Form 4 discloses a routine, pre-planned disposition under a Rule 10b5-1 trading plan adopted March 14, 2025. The transaction involved 77 shares at $760 each, leaving 15,003 shares beneficially owned directly. Given the small absolute size of the sale versus reported holdings, this filing is a routine insider liquidity event rather than a material change to ownership or governance. No additional compensatory or company-level financial data is included.

Corporate Governance Expert

TL;DR: Properly documented Rule 10b5-1 sale; disclosure and signature via attorney-in-fact are consistent with standard insider reporting practices.

The filing states the sale was executed pursuant to a 10b5-1 plan and that shares sold derived from settled vested restricted stock units. The inclusion of the plan adoption date and the attorney-in-fact signature indicates compliance with typical insider trading disclosure protocols. There are no indications of unusual timing or material governance events in this Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Mak Jennifer H

(Last) (First) (Middle)

17800 N 85TH ST

(Street)

SCOTTSDALE AZ 85255

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2025		S(1)		77	D	$760	15,003	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This sale, effected pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025, consisted of shares issued upon the settlement of vested restricted stock units.

Remarks:

	/s/ Jennifer H. Mak by Isaiah Fields, Attorney-in-Fact	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did AXON Chief Accounting Officer Jennifer Mak report on Form 4?

The Form 4 reports a sale of 77 shares of Axon common stock on 09/15/2025, executed under a Rule 10b5-1 trading plan adopted March 14, 2025.

At what price were the AXON shares sold in the Form 4 filed by Jennifer Mak?

The reported sale price was $760 per share.

How many AXON shares did Jennifer Mak own after the reported transaction?

After the sale, she beneficially owned 15,003 shares directly.

Why does the Form 4 mention a Rule 10b5-1 trading plan?

The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted March 14, 2025, indicating the transaction was pre-planned and executed under that program.

Who signed the Form 4 for Jennifer Mak?

The Form 4 is signed by Isaiah Fields, Attorney-in-Fact for Jennifer H. Mak dated 09/15/2025.